共 50 条
- [31] Afatinib alone or afatinib plus vinorelbine versus investigator's choice of treatment for HER2-positive breast cancer with progressive brain metastases after trastuzumab, lapatinib, or both (LUX-Breast 3): a randomised, open-label, multicentre, phase 2 trialLANCET ONCOLOGY, 2015, 16 (16): : 1700 - 1710Cortes, Javier论文数: 0 引用数: 0 h-index: 0机构: Vall dHebron Inst Oncol, Barcelona 08035, Spain Hosp Ramon & Cajal, E-28034 Madrid, Spain Vall dHebron Inst Oncol, Barcelona 08035, SpainDieras, Veronique论文数: 0 引用数: 0 h-index: 0机构: Inst Curie, Paris, France Vall dHebron Inst Oncol, Barcelona 08035, SpainRo, Jungsil论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Goyang Si, South Korea Vall dHebron Inst Oncol, Barcelona 08035, SpainBarriere, Jerome论文数: 0 引用数: 0 h-index: 0机构: Ctr Antoine Lacassagne, F-06054 Nice, France Vall dHebron Inst Oncol, Barcelona 08035, SpainBachelot, Thomas论文数: 0 引用数: 0 h-index: 0机构: Ctr Leon Berard, F-69373 Lyon, France Vall dHebron Inst Oncol, Barcelona 08035, SpainHurvitz, Sara论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Los Angeles, CA USA Vall dHebron Inst Oncol, Barcelona 08035, SpainLe Rhun, Emilie论文数: 0 引用数: 0 h-index: 0机构: Ctr Oscar Lambret, F-59020 Lille, France Univ Hosp, Lille, France Vall dHebron Inst Oncol, Barcelona 08035, SpainEspie, Marc论文数: 0 引用数: 0 h-index: 0机构: Hop St Louis, Paris, France Vall dHebron Inst Oncol, Barcelona 08035, SpainKim, Sung-Bae论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea Vall dHebron Inst Oncol, Barcelona 08035, SpainSchneeweiss, Andreas论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp, Natl Ctr Tumor Dis, Heidelberg, Germany Vall dHebron Inst Oncol, Barcelona 08035, SpainSohn, Joo Hyuk论文数: 0 引用数: 0 h-index: 0机构: Severance Hosp, Seoul, South Korea Vall dHebron Inst Oncol, Barcelona 08035, SpainNabholtz, Jean-Marc论文数: 0 引用数: 0 h-index: 0机构: Ctr Jean Perrin, Clermont Ferrand, France Vall dHebron Inst Oncol, Barcelona 08035, Spain论文数: 引用数: h-index:机构:Taguchi, Julie论文数: 0 引用数: 0 h-index: 0机构: Sansum Clin, Santa Barbara, CA USA Vall dHebron Inst Oncol, Barcelona 08035, SpainPiacentini, Federico论文数: 0 引用数: 0 h-index: 0机构: Univ Modena & Reggio Emilia, Modena, Italy Vall dHebron Inst Oncol, Barcelona 08035, SpainCiruelos, Eva论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ 12 Octubre, Madrid, Spain Vall dHebron Inst Oncol, Barcelona 08035, Spain论文数: 引用数: h-index:机构:Ould-Kaci, Mahmoud论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim GmbH & Co KG, Paris, France Vall dHebron Inst Oncol, Barcelona 08035, SpainRoux, Flavien论文数: 0 引用数: 0 h-index: 0机构: Boehringer Ingelheim GmbH & Co KG, Reims, France Vall dHebron Inst Oncol, Barcelona 08035, Spain论文数: 引用数: h-index:机构:
- [32] Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety studyANNALS OF ONCOLOGY, 2018, 29 (03) : 646 - 653Swain, S. M.论文数: 0 引用数: 0 h-index: 0机构: Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 4000 Reservoir Rd NW,120 Bldg D, Washington, DC 20057 USA Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 4000 Reservoir Rd NW,120 Bldg D, Washington, DC 20057 USAEwer, M. S.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Cardiol, Houston, TX 77030 USA Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 4000 Reservoir Rd NW,120 Bldg D, Washington, DC 20057 USAViale, G.论文数: 0 引用数: 0 h-index: 0机构: Univ Milan, European Inst Oncol, Dept Pathol, Milan, Italy Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 4000 Reservoir Rd NW,120 Bldg D, Washington, DC 20057 USADelaloge, S.论文数: 0 引用数: 0 h-index: 0机构: Inst Gustave Roussy, Dept Med Oncol, Villejuif, France Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 4000 Reservoir Rd NW,120 Bldg D, Washington, DC 20057 USAFerrero, J-M论文数: 0 引用数: 0 h-index: 0机构: Ctr Antoine Lacassagne, Dept Clin Res, Nice, France Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 4000 Reservoir Rd NW,120 Bldg D, Washington, DC 20057 USAVerrill, M.论文数: 0 引用数: 0 h-index: 0机构: Northern Ctr Canc Care, Dept Med Oncol, Newcastle Upon Tyne, Tyne & Wear, England Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 4000 Reservoir Rd NW,120 Bldg D, Washington, DC 20057 USAColomer, R.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ La Princesa, Dept Med Oncol, Madrid, Spain Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 4000 Reservoir Rd NW,120 Bldg D, Washington, DC 20057 USAVieira, C.论文数: 0 引用数: 0 h-index: 0机构: Inst Portugues Oncol Francisco Gentil IPOFG Porto, Med Oncol, Porto, Portugal Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 4000 Reservoir Rd NW,120 Bldg D, Washington, DC 20057 USAWerner, T. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 4000 Reservoir Rd NW,120 Bldg D, Washington, DC 20057 USADouthwaite, H.论文数: 0 引用数: 0 h-index: 0机构: Roche Prod Ltd, Biostat, Prod Dev, Welwyn Garden City, Herts, England Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 4000 Reservoir Rd NW,120 Bldg D, Washington, DC 20057 USABradley, D.论文数: 0 引用数: 0 h-index: 0机构: Roche Prod Ltd, Clin Sci, Global Prod Dev, Welwyn Garden City, Herts, England Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 4000 Reservoir Rd NW,120 Bldg D, Washington, DC 20057 USAWaldron-Lynch, M.论文数: 0 引用数: 0 h-index: 0机构: Roche Prod Ltd, Clin Sci, Global Prod Dev, Welwyn Garden City, Herts, England Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 4000 Reservoir Rd NW,120 Bldg D, Washington, DC 20057 USAKiermaier, A.论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche Ltd, OBD, Basel, Switzerland Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 4000 Reservoir Rd NW,120 Bldg D, Washington, DC 20057 USAEng-Wong, J.论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, Prod Dev Oncol, San Francisco, CA 94080 USA Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 4000 Reservoir Rd NW,120 Bldg D, Washington, DC 20057 USADang, C.论文数: 0 引用数: 0 h-index: 0机构: Mem Sloan Kettering Canc Ctr, Dept Med, Breast Med Serv, 1275 York Ave, New York, NY 10021 USA Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, 4000 Reservoir Rd NW,120 Bldg D, Washington, DC 20057 USA
- [33] Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trialLANCET ONCOLOGY, 2015, 16 (07): : 816 - 829Hurvitz, Sara A.论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Los Angeles, CA 90095 USA论文数: 引用数: h-index:机构:Jiang, Zefei论文数: 0 引用数: 0 h-index: 0机构: Beijing 307 Hosp PLA, Beijing, Peoples R China Univ Calif Los Angeles, Los Angeles, CA 90095 USAShao, Zhimin论文数: 0 引用数: 0 h-index: 0机构: Fudan Univ, Canc Hosp, Dept Breast Surg, Shanghai 200433, Peoples R China Univ Calif Los Angeles, Los Angeles, CA 90095 USAMano, Max S.论文数: 0 引用数: 0 h-index: 0机构: Inst Canc Estado Sao Paulo, Sao Paulo, Brazil Univ Calif Los Angeles, Los Angeles, CA 90095 USANeciosup, Silvia P.论文数: 0 引用数: 0 h-index: 0机构: Inst Nacl Enfermedades Neoplas, Lima, Peru Univ Calif Los Angeles, Los Angeles, CA 90095 USATseng, Ling-Min论文数: 0 引用数: 0 h-index: 0机构: Natl Yang Ming Univ, Taipei Vet Gen Hosp, Taipei 112, Taiwan Univ Calif Los Angeles, Los Angeles, CA 90095 USAZhang, Qingyuan论文数: 0 引用数: 0 h-index: 0机构: Harbin Med Univ, Tumor Hosp, Dept Med Oncol, Harbin, Peoples R China Univ Calif Los Angeles, Los Angeles, CA 90095 USAShen, Kunwei论文数: 0 引用数: 0 h-index: 0机构: Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Shanghai 200030, Peoples R China Univ Calif Los Angeles, Los Angeles, CA 90095 USALiu, Donggeng论文数: 0 引用数: 0 h-index: 0机构: Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou 510275, Guangdong, Peoples R China Univ Calif Los Angeles, Los Angeles, CA 90095 USADreosti, Lydia M.论文数: 0 引用数: 0 h-index: 0机构: Univ Pretoria, Dept Med Oncol, Gauteng, South Africa Univ Calif Los Angeles, Los Angeles, CA 90095 USABurris, Howard A.论文数: 0 引用数: 0 h-index: 0机构: Sarah Cannon Res Inst, Nashville, TN USA Univ Calif Los Angeles, Los Angeles, CA 90095 USA论文数: 引用数: h-index:机构:Buyse, Marc E.论文数: 0 引用数: 0 h-index: 0机构: Int Drug Dev Inst, Louvain La Neuve, Belgium Univ Calif Los Angeles, Los Angeles, CA 90095 USACabaribere, David论文数: 0 引用数: 0 h-index: 0机构: TRIO, Paris, France Univ Calif Los Angeles, Los Angeles, CA 90095 USALindsay, Mary-Ann论文数: 0 引用数: 0 h-index: 0机构: TRIO, Edmonton, AB, Canada Univ Calif Los Angeles, Los Angeles, CA 90095 USARao, Shantha论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Calif Los Angeles, Los Angeles, CA 90095 USAPacaud, Lida Bubuteishvili论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharma AG, Basel, Switzerland Univ Calif Los Angeles, Los Angeles, CA 90095 USATaran, Tetiana论文数: 0 引用数: 0 h-index: 0机构: Novartis Pharmaceut, E Hanover, NJ USA Univ Calif Los Angeles, Los Angeles, CA 90095 USASlamon, Dennis论文数: 0 引用数: 0 h-index: 0机构: Univ Calif Los Angeles, Los Angeles, CA 90095 USA Univ Calif Los Angeles, Los Angeles, CA 90095 USA
- [34] Subcutaneous versus intravenous administration of (neo)adjuvant trastuzumab in patients with HER2-positive, clinical stage I-III breast cancer (HannaH study): a phase 3, open-label, multicentre, randomised trialLANCET ONCOLOGY, 2012, 13 (09): : 869 - 878Ismael, Gustavo论文数: 0 引用数: 0 h-index: 0机构: Hosp Amaral Carvalho, Jau, Brazil Hosp Amaral Carvalho, Jau, BrazilHegg, Roberto论文数: 0 引用数: 0 h-index: 0机构: Byington & FMUSP Sao Paulo, Sao Paulo, Brazil Hosp Amaral Carvalho, Jau, BrazilMuehlbauer, Susanne论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Basel, Switzerland Hosp Amaral Carvalho, Jau, BrazilHeinzmann, Dominik论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche, Basel, Switzerland Hosp Amaral Carvalho, Jau, BrazilLum, Bert论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Hosp Amaral Carvalho, Jau, BrazilKim, Sung-Bae论文数: 0 引用数: 0 h-index: 0机构: Uni Ulsan Coll Med, Asan Med Ctr, Seoul, South Korea Hosp Amaral Carvalho, Jau, BrazilPienkowski, Tadeusz论文数: 0 引用数: 0 h-index: 0机构: Inst Marii Sklodowskiej Curie, Ctr Onkol, Warsaw, Poland Hosp Amaral Carvalho, Jau, BrazilLichinitser, Mikhail论文数: 0 引用数: 0 h-index: 0机构: Blokhin Canc Res Ctr, Moscow, Russia Hosp Amaral Carvalho, Jau, BrazilSemiglazov, Vladimir论文数: 0 引用数: 0 h-index: 0机构: Fed State Estab, St Petersburg, Russia Hosp Amaral Carvalho, Jau, BrazilMelichar, Bohuslav论文数: 0 引用数: 0 h-index: 0机构: Univ Palackeho, Lekarska Fak, Olomouc, Czech Republic Fak Nemocnice, Olomouc, Czech Republic Hosp Amaral Carvalho, Jau, BrazilJackisch, Christian论文数: 0 引用数: 0 h-index: 0机构: Klinikum Offenbach, Offenbach, Germany Hosp Amaral Carvalho, Jau, Brazil
- [35] Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trialLANCET ONCOLOGY, 2019, 20 (12): : 1750 - 1759Park, Yeon Hee论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South KoreaKim, Tae-Yong论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South Korea Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp,Canc Res Inst, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South Korea论文数: 引用数: h-index:机构:Kang, Seok Yun论文数: 0 引用数: 0 h-index: 0机构: Ajou Univ, Sch Med, Dept Hematol Oncol, Suwon, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South KoreaPark, In Hae论文数: 0 引用数: 0 h-index: 0机构: Natl Canc Ctr, Ctr Breast Canc, Goyang, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South KoreaKim, Jee Hyun论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Bundang Hosp, Coll Med, Dept Internal Med, Seongnam, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South Korea论文数: 引用数: h-index:机构:Ahn, Hee Kyung论文数: 0 引用数: 0 h-index: 0机构: Gachon Univ, Gil Med Ctr, Div Med Oncol, Incheon, South Korea Gachon Univ, Gil Med Ctr, Dept Internal Med, Incheon, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South KoreaLee, Moon Hee论文数: 0 引用数: 0 h-index: 0机构: Inha Univ, Sch Med, Dept Internal Med, Incheon, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South KoreaKim, Hee-Jun论文数: 0 引用数: 0 h-index: 0机构: Chung Ang Univ, Coll Med, Dept Internal Med, Seoul, South Korea Soonchunhyang Univ Hosp, Div Hematol & Oncol, Dept Internal Med, Cheonan, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South KoreaKim, Han Jo论文数: 0 引用数: 0 h-index: 0机构: Soonchunhyang Univ Hosp, Div Hematol & Oncol, Dept Internal Med, Cheonan, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South Korea论文数: 引用数: h-index:机构:Koh, Su-Jin论文数: 0 引用数: 0 h-index: 0机构: Ulsan Univ, Coll Med, Dept Hematol & Oncol, Ulsan Univ Hosp, Ulsan, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South KoreaKim, Ji-Yeon论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South KoreaLee, Kyung-Hun论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp,Canc Res Inst, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South KoreaSohn, Joohyuk论文数: 0 引用数: 0 h-index: 0机构: Yonsei Univ, Coll Med, Div Med Oncol, Seoul, South Korea Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South KoreaKim, Sung-Bae论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South KoreaAhn, Jin-Seok论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South KoreaIm, Young-Hyuck论文数: 0 引用数: 0 h-index: 0机构: Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South KoreaJung, Kyung Hae论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Dept Oncol, Asan Med Ctr, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South KoreaIm, Seock-Ah论文数: 0 引用数: 0 h-index: 0机构: Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul Natl Univ Hosp,Canc Res Inst, Seoul, South Korea Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul 06351, South Korea
- [36] Single-arm, neoadjuvant, phase II trial of pertuzumab and trastuzumab administered concomitantly with weekly paclitaxel followed by 5-fluoruracil, epirubicin, and cyclophosphamide (FEC) for stage I–III HER2-positive breast cancerBreast Cancer Research and Treatment, 2018, 169 : 333 - 340Julia Foldi论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Sarah Mougalian论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Andrea Silber论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Donald Lannin论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Brigid Killelea论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Anees Chagpar论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Nina Horowitz论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Courtney Frederick论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Lawrence Rispoli论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Trisha Burrello论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Maysa Abu-Khalaf论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Kert Sabbath论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Tara Sanft论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Debra S. Brandt论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Erin W. Hofstatter论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Christos Hatzis论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Michael P. DiGiovanna论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,Lajos Pusztai论文数: 0 引用数: 0 h-index: 0机构: Yale Cancer Center,
- [37] Pembrolizumab plus eribulin in hormone receptore-positive, HER2-negative, locally recurrent or metastatic breast cancer (KELLY): An open-label, multicentre, single-arm, phase II trialEUROPEAN JOURNAL OF CANCER, 2021, 148 : 382 - 394Perez-Garcia, Jose M.论文数: 0 引用数: 0 h-index: 0机构: Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, Spain Med Scientia Innovat Res MEDSIR, Ridgewood, NJ USA Med Scientia Innovat Res MEDSIR, Barcelona, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainLlombart-Cussac, Antonio论文数: 0 引用数: 0 h-index: 0机构: Med Scientia Innovat Res MEDSIR, Ridgewood, NJ USA Med Scientia Innovat Res MEDSIR, Barcelona, Spain Univ Catolica Valencia San Vicente Martir, Hosp Arnau de Vilanova, Valencia, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainCortes, Maria G.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Ramon y Cajal, Madrid, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainCurigliano, Giuseppe论文数: 0 引用数: 0 h-index: 0机构: Univ Milan, European Inst Oncol IRCCS, Milan, Italy Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainLopez-Miranda, Elena论文数: 0 引用数: 0 h-index: 0机构: Med Scientia Innovat Res MEDSIR, Ridgewood, NJ USA Med Scientia Innovat Res MEDSIR, Barcelona, Spain Hosp Univ Ramon y Cajal, Madrid, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainAlonso, Jose L.论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Univ Virgen de la Arrixaca, Murcia, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainBermejo, Begona论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Valencia, CIBERONC, INCLIVA, Valencia, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainCalvo, Lourdes论文数: 0 引用数: 0 h-index: 0机构: Complejo Hosp Univ A Coruna CHUAC, La Coruna, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainCaranana, Vicente论文数: 0 引用数: 0 h-index: 0机构: Hosp Arnau Vilanova, Valencia, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, Spainde la Cruz Sanchez, Susana论文数: 0 引用数: 0 h-index: 0机构: Complejo Hosp Navarra, Pamplona, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainVazquez, Raul M.论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Madrid, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainPrat, Aleix论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain IDIBAPS, Translat Genom & Targeted Therapies Grp, Barcelona, Spain Univ Barcelona, Dept Med, Barcelona, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainBorrego, Manuel R.论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen del Rocio, Seville, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainSampayo-Cordero, Miguel论文数: 0 引用数: 0 h-index: 0机构: Med Scientia Innovat Res MEDSIR, Ridgewood, NJ USA Med Scientia Innovat Res MEDSIR, Barcelona, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainSegui-Palmer, Miguel A.论文数: 0 引用数: 0 h-index: 0机构: Corp Sanitaria Sanitari Parc Tauli, Sabadell, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainSoberino, Jesus论文数: 0 引用数: 0 h-index: 0机构: QuironSalud Grp, Inst Oncol, IOB, Barcelona, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainMalfettone, Andrea论文数: 0 引用数: 0 h-index: 0机构: Med Scientia Innovat Res MEDSIR, Ridgewood, NJ USA Med Scientia Innovat Res MEDSIR, Barcelona, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainSchmid, Peter论文数: 0 引用数: 0 h-index: 0机构: Queen Mary Univ London, Barts Canc Inst, Barts ECMC, London, England Barts Hosp NHS Trust, London, England Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, SpainCortes, Javier论文数: 0 引用数: 0 h-index: 0机构: Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, Spain Med Scientia Innovat Res MEDSIR, Ridgewood, NJ USA Med Scientia Innovat Res MEDSIR, Barcelona, Spain Vall dHebron Inst Oncol VHIO, Barcelona, Spain Int Breast Canc Ctr IBCC, Quiron Grp, Carrer Vilana 12, Barcelona 08022, Spain
- [38] Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016)JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (11)Pellegrino, Benedetta论文数: 0 引用数: 0 h-index: 0机构: Univ Parma, Dept Med & Surg, Parma, Italy Univ Hosp Parma, Med Oncol & Breast Unit, Parma, Italy Univ Parma, Dept Med & Surg, Parma, ItalyTommasi, Chiara论文数: 0 引用数: 0 h-index: 0机构: Univ Parma, Dept Med & Surg, Parma, Italy Univ Hosp Parma, Med Oncol & Breast Unit, Parma, Italy Univ Parma, Dept Med & Surg, Parma, ItalySerra, Olga论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Parma, Med Oncol & Breast Unit, Parma, Italy Univ Parma, Dept Med & Surg, Parma, ItalyGori, Stefania论文数: 0 引用数: 0 h-index: 0机构: Osped Sacro Cuore Don Calabria Negrar VR, Med Oncol Unit, Negrar, Italy Univ Parma, Dept Med & Surg, Parma, ItalyCretella, Elisabetta论文数: 0 引用数: 0 h-index: 0机构: Osped Bolzano, Med Oncol Unit, Bolzano, Italy Univ Parma, Dept Med & Surg, Parma, ItalyAmbroggi, Massimo论文数: 0 引用数: 0 h-index: 0机构: Hosp Piacenza, Med Oncol, Piacenza, Emilia Romagna, Italy Univ Parma, Dept Med & Surg, Parma, ItalyFrassoldati, Antonio论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Ferrara Arcispedale St Anna, Med Dept, Ferrara, Emilia Romagna, Italy Univ Parma, Dept Med & Surg, Parma, ItalyBisagni, Giancarlo论文数: 0 引用数: 0 h-index: 0机构: Azienda Unita Sanitaria Locale IRCCS Reggio Emili, Azienda Unita Sanit Locale, Reggio Emilia, Emilia Romagna, Italy Univ Parma, Dept Med & Surg, Parma, ItalyCasarini, Chiara论文数: 0 引用数: 0 h-index: 0机构: Osped Sassuolo, Med Oncol Unit, Sassuolo, Modena, Italy Univ Parma, Dept Med & Surg, Parma, ItalyBria, Emilio论文数: 0 引用数: 0 h-index: 0机构: Univ Cattolica Sacro Cuore, Fac Med & Chirurg, Rome, Lazio, Italy Fdn Policlin Univ Agostino Gemelli IRCCS, Ctr Comprehens Canc, Rome, Italy Univ Parma, Dept Med & Surg, Parma, Italy论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Mura, Antonella论文数: 0 引用数: 0 h-index: 0机构: Dept Med Oncol, Azienda USL Bologna, Bologna, Italy Univ Parma, Dept Med & Surg, Parma, ItalyZamagni, Claudio论文数: 0 引用数: 0 h-index: 0机构: Dept Oncol & Hematol, IRCCS Azienda Osped, Univ Bologna, Bologna, Emilia Romagna, Italy Univ Parma, Dept Med & Surg, Parma, ItalyGianni, Lorenzo论文数: 0 引用数: 0 h-index: 0机构: Infermi Hosp, AUSL Romagna, Dept Gynecol, Rimini, Italy Univ Parma, Dept Med & Surg, Parma, ItalyZambelli, Alberto论文数: 0 引用数: 0 h-index: 0机构: Oncol Unit, ASST Papa Giovanni XXIII, Bergamo, Lombardy, Italy Univ Parma, Dept Med & Surg, Parma, ItalyMontemurro, Filippo论文数: 0 引用数: 0 h-index: 0机构: Candiolo Canc Inst, Dept Oncol & Hematol, Candiolo, Italy Univ Parma, Dept Med & Surg, Parma, ItalyTognetto, Michele论文数: 0 引用数: 0 h-index: 0机构: Grp Oncol Ric Clin GOIRC, Parma, Italy Univ Parma, Dept Med & Surg, Parma, ItalyTodeschini, Renata论文数: 0 引用数: 0 h-index: 0机构: Grp Oncol Ric Clin GOIRC, Parma, Italy Univ Parma, Dept Med & Surg, Parma, Italy论文数: 引用数: h-index:机构:Campanini, Nicoletta论文数: 0 引用数: 0 h-index: 0机构: Univ Parma, Dept Med & Surg, Parma, Italy Univ Parma, Dept Med & Surg, Parma, ItalySilini, Enrico Maria论文数: 0 引用数: 0 h-index: 0机构: Univ Parma, Dept Med & Surg, Parma, Italy Univ Parma, Dept Med & Surg, Parma, ItalyMaglietta, Giuseppe论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Parma, Res Unit, Parma, Italy Univ Parma, Dept Med & Surg, Parma, ItalyMusolino, Antonino论文数: 0 引用数: 0 h-index: 0机构: Univ Parma, Dept Med & Surg, Parma, Italy Univ Hosp Parma, Med Oncol & Breast Unit, Parma, Italy Univ Parma, Dept Med & Surg, Parma, Italy
- [39] Chemotherapy de-escalation using an 18F-FDG-PET-based pathological response-adapted strategy in patients with HER2-positive early breast cancer (PHERGain): a multicentre, randomised, open-label, non-comparative, phase 2 trialLANCET ONCOLOGY, 2021, 22 (06): : 858 - 871Manuel Perez-Garcia, Jose论文数: 0 引用数: 0 h-index: 0机构: Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, Spain Med Scientia Innovat Res, Barcelona, Spain Med Scientia Innovat Res, Ridgewood, NJ USA Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainGebhart, Geraldine论文数: 0 引用数: 0 h-index: 0机构: Inst Jules Bordet Univ Libre Bruxelles, Brussels, Belgium Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainRuiz Borrego, Manuel论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Virgen Rocio, Med Oncol Dept, Seville, Spain Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainStradella, Agostina论文数: 0 引用数: 0 h-index: 0机构: Hosp Llobregat, Inst Catala Oncol, Barcelona, Spain Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainBermejo, Begona论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Univ Valencia, Valencia, Spain Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainSchmid, Peter论文数: 0 引用数: 0 h-index: 0机构: Queen Mary Univ London, Barts Expt Canc Med Ctr, Barts Canc Inst, London, England Barts Hosp NHS Trust, London, England Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainMarme, Frederik论文数: 0 引用数: 0 h-index: 0机构: Heidelberg Univ, Med Fac Mannheim, Univ Hosp Heidelberg, Heidelberg, Germany Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainEscriva-de-Romani, Santiago论文数: 0 引用数: 0 h-index: 0机构: Vali dHebron Inst Oncol, Barcelona, Spain Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainCalvo, Lourdes论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ A Coruna, UGC Oncol Interctr, La Coruna, Spain Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainRibelles, Nuria论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ Reg & Virgen Victoria Malaga, Malaga, Spain Inst Invest Biomed Malaga, Med Oncol Serv, Malaga, Spain Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainMartinez, Noelia论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Ramon y Cajal, Med Oncol, Madrid, Spain Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainAlbacar, Cinta论文数: 0 引用数: 0 h-index: 0机构: Hosp Univ St Joan de Reus, Dept Med Oncol, Reus, Spain Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainPrat, Aleix论文数: 0 引用数: 0 h-index: 0机构: Hosp Clin Barcelona, Dept Med Oncol, Barcelona, Spain IDIBAPS, Translat Genom & Targeted Tberapies Grp, Barcelona, Spain Univ Barcelona, Dept Med, Barcelona, Spain Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainDalenc, Florence论文数: 0 引用数: 0 h-index: 0机构: Toulouse Canc Res Ctr, Inst Claudius Regaud, INSERM, IUCT Oncopole, Toulouse, France Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainKerrou, Khaldoun论文数: 0 引用数: 0 h-index: 0机构: Sorbonne Univ, Tenon Hosp IUC UPMC, AP HP, Nucl Med & Pet Ctr Dept, Paris, France Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainColleoni, Marco论文数: 0 引用数: 0 h-index: 0机构: IRCCS European Inst Oncol, Div Med Senolo Gy, Milan, Italy Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainAfonso, Noemia论文数: 0 引用数: 0 h-index: 0机构: Ctr Hosp Univ Porto, Porto, Portugal Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainDi Cosimo, Serena论文数: 0 引用数: 0 h-index: 0机构: Med Scientia Innovat Res, Barcelona, Spain Med Scientia Innovat Res, Ridgewood, NJ USA Fdn IRCCS Ist Nazl Tumori, Dept Appl Res & Technol Dev, Biomarkers Unit, Milan, Italy Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainSampayo-Cordero, Miguel论文数: 0 引用数: 0 h-index: 0机构: Med Scientia Innovat Res, Barcelona, Spain Med Scientia Innovat Res, Ridgewood, NJ USA Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainMalfettone, Andrea论文数: 0 引用数: 0 h-index: 0机构: Med Scientia Innovat Res, Barcelona, Spain Med Scientia Innovat Res, Ridgewood, NJ USA Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainCortes, Javier论文数: 0 引用数: 0 h-index: 0机构: Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, Spain Med Scientia Innovat Res, Barcelona, Spain Med Scientia Innovat Res, Ridgewood, NJ USA Vali dHebron Inst Oncol, Barcelona, Spain Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, SpainLlombart-Cussac, Antonio论文数: 0 引用数: 0 h-index: 0机构: Med Scientia Innovat Res, Barcelona, Spain Med Scientia Innovat Res, Ridgewood, NJ USA Univ Catolica, Hosp Arnau Vilanova, Valencia, Spain Int Breast Canc Ctr, Quiron Grp, Barcelona 08022, Spain
- [40] Trastuzumab emtansine versus treatment of physician's choice in patients with previously treated HER2-positive metastatic breast cancer (TH3RESA): final overall survival results from a randomised open-label phase 3 trialLANCET ONCOLOGY, 2017, 18 (06): : 743 - 754Krop, Ian E.论文数: 0 引用数: 0 h-index: 0机构: Dana Farber Canc Inst, Harvard Med Sch, Boston, MA 02115 USA Dana Farber Canc Inst, Harvard Med Sch, Boston, MA 02115 USAKim, Sung-Bae论文数: 0 引用数: 0 h-index: 0机构: Univ Ulsan, Coll Med, Asan Med Ctr, Seoul, South Korea Dana Farber Canc Inst, Harvard Med Sch, Boston, MA 02115 USAGonzalez Martin, Antonio论文数: 0 引用数: 0 h-index: 0机构: MD Anderson Canc Ctr, Madrid, Spain Dana Farber Canc Inst, Harvard Med Sch, Boston, MA 02115 USALoRusso, Patricia M.论文数: 0 引用数: 0 h-index: 0机构: Yale Univ, Med Ctr, Yale Canc Ctr, New Haven, CT USA Dana Farber Canc Inst, Harvard Med Sch, Boston, MA 02115 USAFerrero, Jean-Marc论文数: 0 引用数: 0 h-index: 0机构: Ctr Antoine Lacassagne, Dept Med Oncol, Nice, France Dana Farber Canc Inst, Harvard Med Sch, Boston, MA 02115 USABadovinac-Crnjevic, Tanja论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche Ltd, Basel, Switzerland Dana Farber Canc Inst, Harvard Med Sch, Boston, MA 02115 USAHoersch, Silke论文数: 0 引用数: 0 h-index: 0机构: F Hoffmann La Roche Ltd, Basel, Switzerland Dana Farber Canc Inst, Harvard Med Sch, Boston, MA 02115 USASmitt, Melanie论文数: 0 引用数: 0 h-index: 0机构: Genentech Inc, San Francisco, CA 94080 USA Dana Farber Canc Inst, Harvard Med Sch, Boston, MA 02115 USAWildiers, Hans论文数: 0 引用数: 0 h-index: 0机构: Univ Hosp Leuven, Leuven, Belgium Dana Farber Canc Inst, Harvard Med Sch, Boston, MA 02115 USA